Oct 10 (Reuters) - Isis Pharmaceuticals Inc :
* BMO raises Isis Pharmaceuticals price target to $17 from $15; rating
outperform
For a summary of rating and price target changes on U.S. companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .1568
For a summary of rating and price target changes on Canadian companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .4899
((Bangalore Newsroom; +1 646 223 8780))